Financials in USD. Standardized financial statements.
A compact view of how USANA Health Sciences, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $925.26M | $854.50M | $921.01M | $998.60M | $1.19B | $1.13B | $1.06B | $1.19B | $1.05B | $1.01B |
| Revenue Growth? | +8.3% | -7.2% | -7.8% | -15.8% | +4.6% | +7.0% | -10.8% | +13.6% | +4.1% | 0.0% |
| Cost of Revenue? | $200.85M | $175.75M | $189.40M | $207.28M | $230.93M | $222.86M | $202.03M | $217.44M | $195.36M | $193.67M |
| Gross Profit? | $724.40M | $678.75M | $731.62M | $791.32M | $955.53M | $911.79M | $858.87M | $971.81M | $851.90M | $812.41M |
| Gross Margin? | +78.3% | +79.4% | +79.4% | +79.2% | +80.5% | +80.4% | +81.0% | +81.7% | +81.3% | +80.7% |
| Operating Expenses? | $673.54M | $612.43M | $638.54M | $683.70M | $785.34M | $735.29M | $712.68M | $783.46M | $719.40M | $673.79M |
| Operating Income? | $50.86M | $66.32M | $93.07M | $107.61M | $170.19M | $176.49M | $146.19M | $188.35M | $132.50M | $138.62M |
| EBITDA? | $82.07M | $98.86M | $123.11M | $130.22M | $192.89M | $200.96M | $168.98M | $188.35M | $132.50M | $152.10M |
| Income Before Tax | $41.53M | $76.35M | $102.45M | $108.62M | $170.64M | $177.95M | $150.50M | $191.51M | $134.64M | $138.55M |
| Income Tax Expense | $30.05M | $34.29M | $38.66M | $39.27M | $54.14M | $53.28M | $49.97M | $65.29M | $72.11M | $38.51M |
| Net Income? | $10.76M | $42.03M | $63.79M | $69.35M | $116.50M | $124.66M | $100.53M | $126.22M | $62.53M | $100.04M |
| EPS? | $0.58 | $2.20 | $3.33 | $3.60 | $5.78 | $5.89 | $4.44 | $5.36 | $2.60 | $4.09 |
| Diluted EPS? | $0.58 | $2.19 | $3.30 | $3.59 | $5.73 | $5.86 | $4.41 | $5.12 | $2.53 | $3.99 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality